Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer

From MaRDI portal

(Redirected from Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer)

Jump to:navigation, search

WARNING: Page is not linked to a MaRDI-Entity. Please add Sitelink / Wikibase-link.

Retrieved from "https://portal.mardi4nfdi.de/w/index.php?title=Study_of_dose-dependent_combination_immunotherapy_using_engineered_T_cells_and_IL-2_in_cervical_cancer&oldid=64637259"